Biotech

All Articles

Genentech to close cancer immunology investigation team

.Genentech will certainly shut its own cancer cells immunology research team, and unit head and also...

Kezar loses strong tumor but to verify its well worth in phase 1 trial

.Kezar Life Sciences is dropping its own dim stage 1 solid lump medicine as the biotech goes all-in ...

Acelyrin loses izokibep, dismisses 3rd of workers

.Despite izokibep keeping its newfound winning touch in the medical clinic, Acelyrin is actually no ...

Rivus' phase 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid stops preclinical work, IV course after soticlestat stop working

.Ovid Therapeutics already revealed last month that it was trimming its own headcount as the busines...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened a $700 million R&ampD facility in the Boston Port, enhancing its RNA and also ...

Boundless Biography produces 'reasonable' layoffs 5 months after $100M IPO

.Just 5 months after getting a $100 thousand IPO, Boundless Biography is actually already giving up ...

Halda's $126M will certainly progress 'keep as well as get rid of' tumor medicines

.The preliminary stages of oncology R&ampD aren't short of fascinating new modalities, and Halda Reh...

Lykos 'regrets' certainly not revealing research study infractions along with publisher

.Psychopharmacology has pulled three write-ups regarding midstage scientific test data evaluating Ly...

Analysts examine Avidity's DMD win, showing distinctions in data

.Avidity Biosciences impressed capitalists along with phase 1/2 information in Duchenne muscular dys...